PROGENICS PHARMACEUTICALS IN COM
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN COM Stock, CUSIP 743187106.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN COM Stock, CUSIP 743187106.